Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection
Polymyxin B (PMB) is increasingly used as a last-line antibiotic; however, the emergence of PMB resistance is a serious threat to global health. Here, a total of 40 Acinetobacter baumannii clinical isolates were collected to screen for PMB-resistant strains. Several clinical isolates including NCCP...
Main Authors: | Misung Kim, Jaeeun Park, Woojun Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Virulence |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21505594.2020.1867421 |
Similar Items
-
Comparative genomics of two ST 195 carbapenem-resistant Acinetobacter baumannii with different susceptibility to polymyxin revealed underlying resistance mechanism
by: Soo Sum eLean, et al.
Published: (2016-01-01) -
Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01) -
A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii
by: Jaeeun Park, et al.
Published: (2021-06-01) -
Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar
by: Pierrette Landrie Simo Tchuinte, et al.
Published: (2019-02-01) -
Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant Acinetobacter baumannii Clone Expanding in a Teaching Hospital
by: Letícia Dias de Melo Carrasco, et al.
Published: (2021-03-01)